Global Europium Nanoparticle in Biological Sector Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Europium Nanoparticle in Biological Sector market size will reach US$ 25.4 million by 2031.
Europium (Eu), a rare earth element, has been widely explored for its applications in biological immunofluorescence diagnosis due to its unique luminescent properties. Here is an overview of why and how it's used: Long Fluorescence Lifetimes: Europium complexes have fluorescence lifetimes of microseconds to milliseconds, which are significantly longer than conventional organic fluorophores. This time gap allows researchers to perform time-gated detection, reducing autofluorescence from biomolecules and background noise, thus improving the sensitivity and accuracy of assays. High Stability: Europium chelates or cryptates are highly stable, providing consistent fluorescence signals that don't photobleach. The stability of these fluorescent compounds ensures the reliability of diagnostic tests over extended periods. Sharp Emission Spectra: Europium complexes exhibit sharp emission spectral peaks, which enables multiplexing, meaning several different probes can be detected simultaneously without overlap. This is particularly useful in high-throughput screening or when it's necessary to detect multiple targets at once. In terms of application in biological immunofluorescence diagnosis, europium-labeled immunoassays are commonly used. These techniques involve creating a complex between europium and an antibody specific to the target antigen. When the antigen is present, the europium-labelled antibody binds to it. The resulting complex can then be detected through the characteristic fluorescence of europium, allowing accurate identification and quantification of the target antigen. Overall, the use of europium in biological immunofluorescence diagnostics continues to be a promising field, potentially contributing to the development of more accurate, sensitive, and high-throughput diagnostic methods.
Europium's prolonged fluorescence emission has made it a popular choice for time-resolved fluorometry, a technique often used in immunoassays to increase signal-to-noise ratio, providing highly accurate results.
The development of Europium-doped nanoparticles has expanded potential applications in diagnostics. They provide enhanced stability, sensitivity, and specificity in detecting biomarkers for various diseases.
Initiatives by governments and health organizations worldwide to improve healthcare infrastructure and diagnostic capabilities could lead to greater adoption of advanced diagnostic techniques, including Europium-based immunofluorescence.
With increasing incidences of diseases such as cancer, cardiovascular disease, and diabetes, there's a growing need for advanced diagnostic techniques. Europium-based fluorescence assays could play a key role due to their high sensitivity and specificity.
LPI (LP Information)' newest research report, the “Europium Nanoparticle in Biological Sector Industry Forecast” looks at past sales and reviews total world Europium Nanoparticle in Biological Sector sales in 2024, providing a comprehensive analysis by region and market sector of projected Europium Nanoparticle in Biological Sector sales for 2025 through 2031. With Europium Nanoparticle in Biological Sector sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Europium Nanoparticle in Biological Sector industry.
This Insight Report provides a comprehensive analysis of the global Europium Nanoparticle in Biological Sector landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Europium Nanoparticle in Biological Sector portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Europium Nanoparticle in Biological Sector market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Europium Nanoparticle in Biological Sector and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Europium Nanoparticle in Biological Sector.
This report presents a comprehensive overview, market shares, and growth opportunities of Europium Nanoparticle in Biological Sector market by product type, application, key players and key regions and countries.
Segmentation by Type:
300 nm
200 nm
100 nm
Other
Segmentation by Application:
Tumor Marker Testing
Thyroid Function Testing
Sex Hormone Testing
Infectious Disease Testing
Cardiovascular and Cardiac Biomarkers Testing
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Merk
Bangs Laboratories, Inc.
Suzhou NanoMicro Technology Co
Polysciences Inc
CD Bioparticles
Hangzhou Bioeast Biotech Co
Nanjing Microdetection
PuriMag
YUAN BIOTECH
Please note: The report will take approximately 2 business days to prepare and deliver.
Europium (Eu), a rare earth element, has been widely explored for its applications in biological immunofluorescence diagnosis due to its unique luminescent properties. Here is an overview of why and how it's used: Long Fluorescence Lifetimes: Europium complexes have fluorescence lifetimes of microseconds to milliseconds, which are significantly longer than conventional organic fluorophores. This time gap allows researchers to perform time-gated detection, reducing autofluorescence from biomolecules and background noise, thus improving the sensitivity and accuracy of assays. High Stability: Europium chelates or cryptates are highly stable, providing consistent fluorescence signals that don't photobleach. The stability of these fluorescent compounds ensures the reliability of diagnostic tests over extended periods. Sharp Emission Spectra: Europium complexes exhibit sharp emission spectral peaks, which enables multiplexing, meaning several different probes can be detected simultaneously without overlap. This is particularly useful in high-throughput screening or when it's necessary to detect multiple targets at once. In terms of application in biological immunofluorescence diagnosis, europium-labeled immunoassays are commonly used. These techniques involve creating a complex between europium and an antibody specific to the target antigen. When the antigen is present, the europium-labelled antibody binds to it. The resulting complex can then be detected through the characteristic fluorescence of europium, allowing accurate identification and quantification of the target antigen. Overall, the use of europium in biological immunofluorescence diagnostics continues to be a promising field, potentially contributing to the development of more accurate, sensitive, and high-throughput diagnostic methods.
Europium's prolonged fluorescence emission has made it a popular choice for time-resolved fluorometry, a technique often used in immunoassays to increase signal-to-noise ratio, providing highly accurate results.
The development of Europium-doped nanoparticles has expanded potential applications in diagnostics. They provide enhanced stability, sensitivity, and specificity in detecting biomarkers for various diseases.
Initiatives by governments and health organizations worldwide to improve healthcare infrastructure and diagnostic capabilities could lead to greater adoption of advanced diagnostic techniques, including Europium-based immunofluorescence.
With increasing incidences of diseases such as cancer, cardiovascular disease, and diabetes, there's a growing need for advanced diagnostic techniques. Europium-based fluorescence assays could play a key role due to their high sensitivity and specificity.
LPI (LP Information)' newest research report, the “Europium Nanoparticle in Biological Sector Industry Forecast” looks at past sales and reviews total world Europium Nanoparticle in Biological Sector sales in 2024, providing a comprehensive analysis by region and market sector of projected Europium Nanoparticle in Biological Sector sales for 2025 through 2031. With Europium Nanoparticle in Biological Sector sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Europium Nanoparticle in Biological Sector industry.
This Insight Report provides a comprehensive analysis of the global Europium Nanoparticle in Biological Sector landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Europium Nanoparticle in Biological Sector portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Europium Nanoparticle in Biological Sector market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Europium Nanoparticle in Biological Sector and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Europium Nanoparticle in Biological Sector.
This report presents a comprehensive overview, market shares, and growth opportunities of Europium Nanoparticle in Biological Sector market by product type, application, key players and key regions and countries.
Segmentation by Type:
300 nm
200 nm
100 nm
Other
Segmentation by Application:
Tumor Marker Testing
Thyroid Function Testing
Sex Hormone Testing
Infectious Disease Testing
Cardiovascular and Cardiac Biomarkers Testing
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Merk
Bangs Laboratories, Inc.
Suzhou NanoMicro Technology Co
Polysciences Inc
CD Bioparticles
Hangzhou Bioeast Biotech Co
Nanjing Microdetection
PuriMag
YUAN BIOTECH
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
90 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Europium Nanoparticle in Biological Sector Market Size by Player
- 4 Europium Nanoparticle in Biological Sector by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Europium Nanoparticle in Biological Sector Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
